In 2562 patients analysed (2770 enrolled) undergoing ERCP in China, 50 mg rectal indomethacin was non-inferior to 100 mg for preventing post-ERCP pancreatitis: 8.1% vs 7.7% (risk difference 0.38%, 95% CI -1.71 to 2.47).
RCTn = 2,770
Qi et al. Low-dose rectal indomethacin to prevent post-ERCP pancreatitis: results of a large Chinese multicenter randomized noninferiority trial